Abstract
“Angiogenesis” is currently used to describe the growth of new capillary blood vessels by sprouting from established vessels to produce “neovascularization.” “Vasculogenesis” denotes the development of blood vessels in the embryo (Risau and Lemmon 1988; Feinberg and Beebe 1983). There is as yet no adequate term to describe the growth of larger vessels such as coronary artery collaterals where actual proliferation of vascular endothelium and smooth muscle lead to enlargement of the lumenal diameter (Schaper 1981; Pasyk et al. 1982; D’amore and Thompson 1987). Nor is there a description of endothelial proliferation in the capillaries of hypertrophic heart muscle in the apparent absence of sprouting (Hudlicka and Tyler 1986). However, the term “non- sprouting angiogenesis” is useful (Folkman 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel MH (1985) Prostanoids and menstruation. In: Baird DT, Michie EA (eds) Mechanism of menstrual bleeding. Raven, New York, pp 139–156
Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233: 545–548
Algire GH (1943) Microscopic studies of the early growth of a transplantable melanoma of the mouse, using the transparent-chamber technique. JNCI 4: 13–20
Anzano MA, Roberts AB, Smith JM, Sporn MB, DeLarco JE (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and type ß transforming growth factors. Proc Natl Acad Sci USA 80: 6264–6268
Anzano MA, Roberts AB, Sporn MB (1986) Anchorage independent growth of primary rat embryo cells is induced by platelet-derived growth factor and inhibited by type-ß transforming growth factor. J Cell Physiol 126: 312–318
Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-beta in human platelets. J Biol Chem 258: 7155–7160
Auerbach R (1981) Angiogenesis-inducing factors: a review. In: Pick E (ed) Lympho-kines. Academic, London, pp 69–88
Auerbach R, Kubai L, Knighton D, Folkman J (1974) A simple procedure for the long- term cultivation of chicken embryos. Dev Biol 41: 391–394
Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14: 53–65
Ausprunk DH, Knighton DR, Folkman J (1974) Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev Biol 38: 237–248
Azizkhan R, Azizkhan J, Zetter B, Folkman J (1980) Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 152: 931–944
Azizkhan JC, Sullivan R, Azizkhan R, Zetter B, Klagsbrun M (1983) The stimulation of capillary endothelial cell migration by chondrosarcoma-derived growth factors. Cancer Res 43: 3281–3286
Baird A, Durkin T (1986) Inhibition of endothelial cell proliferation by type-beta transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 138: 476–482
Baird A, Ling N (1987) Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochem Biophys Res Commun 142: 428–435
Baird A, Mormede P, Bohlen P (1985) Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126: 358–364
Baird A, Esch F, Mormede P, Ueno N, Ling N, Bohlen P, Ying SY, Wehrenberg W, Guillemin R (1986) Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. In. Greep RO (ed) Recent progress in hormone research, vol 42. Academic, New York, pp 143: 205
Banda MJ, Knighton DR, Hunt TK, Werb Z (1982) Isolation of a nonmitogenic angiogenesis factor from wound fluid. Proc Natl Acad Sci USA 79: 7773–7777
Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparanase and heparin-like molecules. Biochemistry 28: 1737–1743
Basset D (1943) The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle. Am J Anat 73: 251–291
Ben Ezra D (1978) Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractants. Am J Ophthalmol 86: 455–461
Beutler B, Cerami A (1986) Cachetin and tumour necrosis factor as two sides of the same biological coin. Nature 320: 584–588
Beutler B, Mahoney J, LeTrang N, Pekala P, Cerami A (1985) Purification of cachectin, a lipoprotein lipase suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 161: 984–995
Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr (1985) Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 76: 2003–2011
Bicknell R, Vallee BL (1988) Angiogenin activates endothelial cell phospholipase C. Proc Natl Acad Sci USA 85: 5961–5965
Bohlen P, Baird A, Esch F, Ling N, Gospodarowicz D (1984) Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci USA 81: 5364–5368
Bond MD, Vallee BL (1988) Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay. Biochemistry 27: 6282
Brem S, Folkman J (1975) Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141: 427–438
Brem S, Cotran R, Folkman J (1972) Tumor angiogenesis: a quantitative method for histologic grading. JNCI 48: 347–356
Brown RA, Weis JB, Tomlinson IW, Philipps P, Kumar S (1980) Angiogenic factor from synovial fluid resembling that from tumors. Lancet 8170: 682–685
Burger PC, Chandler DB, Klintworth GK (1983) Corneal neovascularization as studied by scanning electron microscopy of vascular casts. Lab Invest 48: 169–180
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin- nduced serum factor that causes tumor necrosis. Proc Natl Acad Sci USA 72: 3666–3670
Castellot JJ, Karnovsky MJ, Spiegelman BM (1980) Potent stimulation of vascular endothelial cell growth by differentiated 3T3 adipocytes. Proc Natl Acad Sci USA 77: 6007–6011
Castellot JJ Jr, Karnovsky MJ, Spiegelman BM (1982) Differentiation-dependent stimulation of neovascularization and endothelial cell chemotaxis by 3T3 adipo-cytes. Proc Natl Acad Sci USA 79: 5597–5601
Cavallo T, Sade R, Folkman J, Cotran RS (1972) Tumor angiogenesis: rapid induction of endothelial mitoses demonstrated by autoradiography. J Cell Biol 54: 408–420
Choay J, Petitou M, Lormeau JC, Sinay P, Casu B, Gatti G (1983) Structureactivity relationship of heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem Biophys Res Commun 116: 492–499
Colburn P, Buonassissi V (1978) Estrogen-binding sites in endothelial cell cultures. Science 201: 817–819
Conn G, Hatcher VB (1984) The isolation and purification of two anionic endothelial cell growth factors from human brain. Biochem Biophys Res Commun 124: 262–268
Connolly DT, Stoddard BL, Harakas NK, Feder J (1987) Human fibroblast-derived growth factor is a mitogen and chemoattractant for endothelial cells. Biochem Biophys Res Commun 144: 705–712
Courty J, Loret C, Moenner M, Chevallier B, Lagente O, Courtois Y, Barritault D (1985) Bovine retina contains three growth factor activities with different affinity for heparin: eye-derived growth factor I, II, and III. Biochimie 67: 265–269
Crisp A, Chapman CM, Kirkham SE, Schiller AL, Krane SM (1984) Articular mastrocytosis in rheumatoid arthritis. Arthritis Rheum 27: 845–851
Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375–1378
Cutherbertson RA, Mandel TE (1986) Anatomy of the mouse retina. Endothelial cellpericyte ratio and capillary distribution. Invest Ophthalmol Vis Sci 26: 68–73
D’Amore PA, Klagsbrun M (1984) Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities. J Cell Biol 99: 1545–1549
D’Amore PA, Thompson RW (1987) Collateralization in peripheral vascular disease. In: Strandness D, Didsheim P, Clowes A, Watson J (eds) Vascular diseases. Grune and Stratton, Orlando, pp 319–333
Davidson JM, Klagsbrun M, Hill KE, Buckley A, Sullivan R, Brewer S, Woodward SC (1985) Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J Cell Biol 100: 1219–1227
Delli Bovi PD, Basilico C (1987) Homology between fibroblast growth factor and a transforming gene from Kaposi’s sarcoma. Proc Natl Acad Sci USA 84: 5660–5664
Delli Bovi P, Curatola AM, Newman KM, Sato Y, Moscatelli D, Hewick RM, Rifkin DB, Basilico C (1988) Processing, secretion and biological properties of a novel growth factor of the fibroblast growth family with oncogenic potential. Mol Cell Biol 8: 2933–2941
Denekamp J (1984) Vasculature as a target for tumour therapy. In: Hammersen F, Hudlicka O (eds) Progress in applied microcirculation. Karger, Basel, pp 28–38
Derynck R, Roberts AB, Winkler ME, Chen EY, Goeddel DV (1984) Human transforming growth factor-a: precursor structure and expression in Ecoli. Cell 38: 287–297
Derynck R, Roberts AB, Eaton DH, Winkler ME, Goeddel DV (1985) Human transforming growth factor-alpha: precursor sequence, gene structure and heterologous expression. In: Feramisco J, Ozanne B, Stiles C (eds) Cancer cells, vol 3. Growth factors and transformation. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 79–86
Dickson C, Peters G (1987) Potential oncogene product related to growth factors. Nature 326: 833
DiZerega G, HodgenG (1980) Fluorescence localization of luteinizing hormone/human chorionic gonadotropin uptake in the primate ovary. II. Changing distribution during selection of dominant follicle. J Clin Endocrinol Metab 51: 903–907
Dobson DE, Castellot JJ, Spiegelman BM (1985) Angiogenesis stimulated by 3T3-adipocytes is mediated by prostanoid lipids. J Cell Biol 101: 109a
D’Oliveira F (1966) Pericytes and diabetic retinopathy. Br J Ophthalmol 50: 134–143
Dugan JD Jr, Roberts AB, Sporn MB, Glaser BM (1988) Transforming growth factor beta (TGFß) inhibits neovascularization in vivo. J Cell Biol 107:579 a
Dusseau JW, Hutchins PM, Malbasa DS (1986) Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 59: 163–170
Duthu GS, Smith JR (1980) In vitro proliferation and lifespan of bovine aorta endothelial cells: effect of culture conditions and fibroblast growth factor. J Cell Physiol 103: 385–392
Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650–1659
Edwards RG (1980) Conception in the human female. Academic, London
Ehrmann RL, Knoth M (1968) Choriocarcinoma: transfilter stimulation of vasopro liferation in the hamster cheek pouch - studied by light and electron microscopy. JNCI 41: 1329–1341
Eisenstein R, Sorgente N, Soble L, Miller A, Kuettner KE (1973) The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 73: 765–774
Emerman JT, Pitelka DR (1977) Maintenance and induction of morphological differentiation in dissociated mammary epithelium of floating collagen membranes. In Vitro 13: 316–328
Engerman RL, Pfaffenbach D, Davis MD (1967) Cell turnover of capillaries. Lab Invest 17: 738–743
Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R ( 1985 a) Primary structure of bovine pituitary basic fibro-blast growth factor ( FGF) and comparison with the amino-terminal sequence of bovine acidic FGF. Proc Natl Acad Sci USA 82: 6507–6511
Esch F, Ueno N, Baird A, Hill F, Denoroy L, Ling N, Gospodarowicz D, Guillemin R ( 1985 b) Primary structure of bovine brain acidic fibroblast growth factor ( FGF ). Biochem Biophys Res Commun 133: 554–562
Feinberg RN, Beebe DC (1983) Hyaluronate in vasculogenesis. Science 220: 1177–1179
Fenselau A, Watt S, Mello RJ (1981) Tumor angiogenic factor: purification from the Walker 256 rat tumor. J Biol Chem 256: 9605–9611
Ferenczy A, Bertrand G, Gelfand MM (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 133: 859–867
Fett JW, Strydom DJ, Lobb RF, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24: 480–5486
Findlay JK (1986) Angiogenesis in reproductive tissues. J Endocrinol 111: 357–366
Foley MF, Griffin BD, Zuzel M, Aparicio SR, Bradbury K, Bird CC, Clayton JK, Jenkins DM, Scott JS, Rajah CM, McNicol GP (1978) Heparin-like activity in uterine fluid. Br Med J 11: 322–324
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182–1186
Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409–416
Folkman J (1974 a) Tumor angiogenesis factor. Cancer Res 34:2109–2113
Folkman J (1974b) Tumor angiogenesis. Adv Cancer Res 19: 331–358
Folkman J (1984) Angiogenesis. In: Jaffe EA (ed) Biology of endothelial cells. Martinus Nijhoff, Boston, pp 412–28
Folkman J ( 1985 a) Angiogenesis and its inhibitors. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Important advances in onoclogy. Lippincott, Philadelphia, pp 42–62
Folkman J ( 1985 b) Tumor angiogenesis. In: Klein G, Weinhouse S Advances in Cancer Research. Academic, New York, pp 175–203
Folkman J (1986) How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 46: 467–473
Folkman J (1987) Angiogenesis. In: Verstraete M, Vermylen J, Lijnan R, Arnout J (eds) Thrombosis and haemostasis. Leuven University Press, Leuven, pp 583–596
Folkman J, Haudenschild C (1980) Angiogenesis in vitro. Nature 288: 551–556
Folkman J, Hochberg M (1973) Self-regulation of growth in three dimensions. J Exp Med 138: 745–753
Folkman J, Ingber DE (1987) Angiostatic steroids: method of discovery and mechanism of action. Ann Surg 206: 374–384
c
Folkman J, Klagsbrun M (1987 b) A family of angiogenic peptides. Nature 329: 671–672
Folkman J, Moscona A (1978) Role of cell shape in growth control. Nature 273: 346–349
Folkman J, Merler E, Abernathy C, Williams C (1971) Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133: 275–288
Folkman J, Knighton D, Klagsbrun M (1976) Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res 36: 110–114
Folkman J, Haudenschild C, Zetter BR (1979) Long-term culture of capillary endothelial cells. Proc Natl Acad Sci USA 76: 5217–5221
Folkman J, Langer R, Linhardt R, Haudenschild C, Taylor S (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221: 719–725
Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I (1988) Heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 130: 393–400
Folkman J, Weisz P, Joullie M, Li W, Ewing W (1989 a) Control of angiogenesis with synthetic heparin substitutes. Science 243: 1490–1493
Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58–61
Form DM, Auerbach R (1983) PGE2 and angiogenesis. Proc Soc Exp Biol Med 172: 214–218
Fräser RA, Ellis M, Stalker AL (1979) Experimental angiogenesis in the chorioal-lantoic membrane. In: Lewis DH (ed) Current advances in basic and clinical micro- circulatory research. Karger, Basel, p 25
Frater-Schroder M, Muller G, Birchmeier W, Bohlen P (1986) Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun 137: 295–302
Frater-Schroder M, Risau W, Hallmann R, Gautschi R, Bohlen P (1987) Tumor necrosis factor type-a, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84: 5277–5281
Frederick JL, Shimanuki T, DiZerega GS (1984) Initiation of angiogenesis by human follicular fluid. Science 224: 389–390
Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB (1983) Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci USA 80: 3676–3680
Garner A (1986) Ocular angiogenesis. Int J Exp Pathol 28: 249–309
Gimbrone MA Jr, Leapman S, Cotran RS, Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261–276
Gimbrone MA Jr, Cotran RS, Folkman J ( 1973 a) Endothelial regeneration and turnover. Studies with human endothelial cell cultures. Ser Haematol 6: 453–455
Gimbrone MA Jr, Leapman S, Cotran R, Folkman J (1973 b) Tumor angiogenesis: iris neovascularization at a distance from experimental intraocular tumors. JNCI 50: 219–228
Gimbrone MA Jr, Cotran RS, Folkman J (1974) Tumor growth neovascularization: an experimental model using rabbit cornea. JNCI 52: 413–427
Gimenez-Gallego G, Conn G, Hatcher VB, Thomas KA (1986) Human brain-derived acidic and basic fibroblast growth factors: amino terminal sequences and specific mitogenic activities. Biochem Biophys Res Commun 135: 541–548
Glaser BM, D’Amore PA, Seppa H, Seppa S, Schiffmann E (1980) Adult tissues contain chemoattractants for vascular endothelial cells. Nature 288: 483–484
Goldsmith HS, Griffith AL, Kupferman A, Catsimpoolas N (1984) Lipid angiogenic factor from omentum. JAMA 252: 2034–2036
Gospodarowicz D (1974) Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249: 123–129
Gospodarowicz D (1975) Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem 250: 2515–2520
Gospodarowicz D, Cheng J (1986) Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475–484
Gospodarowicz D, Thakral K (1978) Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc Natl Acad Sci USA 75: 847–851
Gospodarowicz D, Moran J, Braun D, Birdwell CR (1976) Clonal growth of bovine endothelial cells in culture: fibroblast growth factor as a survival factor. Proc Natl Acad Sci USA 73: 4120–4124
Gospodarowicz D, Cheng J, Lui GM, Baird A, Bohlen P (1984) Isolation by heparin- Sepharose affinity chromatography of brain fibroblast growth factor: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci USA 81: 6963–6967
Gospodarowicz D, Cheng J, Lui G, Baird A, Esch F, Bohlen P (1985) Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 117: 2383–2391
Gray PW, Aggarwal BB, Benten CV, Bringman TS, Henzel WJ, Jarrett JA, Leung DW, Moffat B, Ng P, Sverdersky LP, Palladino MA, Nedwin GE (1984) Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature 320: 584–588
Greenblatt M, Shubik P (1968) Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. JNCI 41: 111–124
Gross JL, Moscatelli D, Jaffe EA, Rifkin DB (1982) Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol 95: 974–981
Gross JL, Moscatelli D, Rifkin DB (1983) Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci USA 80: 2623–2627
Haranaka KE, Carswell A, Williamson BD, Prendergast JS, Satomi N, Old LJ (1986) Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci USA 83: 3949–3953
Harris AK, Wild P, Stopak D (1980) Silicone rubber substrata: a new wrinkle in the study of cell locomotion. Science 208: 177–179
Haudenschild CC (1980) Growth control of endothelial cells in atherogenesis and tumor angiogenesis. In: Altura BM, Davis E, Harders H (eds) Vascular endothelium and basement membranes. Karger, Basel, pp 226–251 (Advances in microcirculation, vol 9 )
Haudenschild CC, Zahniser D, Folkman J, Klagsbrun M (1976) Human endothelial cells in culture. Lack of response to serum growth factors. Exp Cell Res 98: 175–183
Hauschka PV, Iafrati TA, Doleman SD, Klagsbrun M (1986) Growth factors in bone matrix: isolation of multiple types by affinity chromatography on heparin-Sepha- rose. J Biol Chem 261:12 665–12 674
Heimark RL, Twardzik DR, Schwartz SM (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233: 1078–1080
Herman IM, D’Amore PA (1985) Microvascular pericytes contain muscle and non-muscle actin. J Cell Biol 101: 43–52
Hobbs JF, Cliff WJ (1971) Observations on tissue grafts established in rabbit ear chambers. A combined light and electron microscopy study. J Exp Med 134: 963–971
Hockel M, Sasse J, Wissler JH (1987) Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and “tube formation” but not proliferation of capillary endothelial cells in vitro. J Cell Physiol 133: 1–13
Hockel M, Jung W, Vaupel P, Rabes H, Khaledpour C, Wissler JH (1988) Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin. J Clin Invest 82: 1075–1090
Hudlicka O, Tyler KR (1986) Angiogenesis: the growth of the vascular system. Academic press, London, pp 101–120
Hunt TK (1980) Wound healing and wound infection: theory and surgical practice. Appleton-Century-Crofts, New York
Iberg N, Rogelt S, Fanning P, Klagsbrun M (1989) Purification of 18- and 22 kDa forms of basic fibroblast growth factor from rat cells transformed by the ras oncogene. J Biol Chem 264: 19951–19955
Ignotz R, Massague J (1986) Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261: 4337–4345
Ingber DE, Folkman J (1988) Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59: 44–51
Ingber DE, Jamieson JD (1985) Cell as tensegrity structures: architectural regulation of histodifferentiation by physical forces transduced over basement membrane. In: Anderson LC, Gahmberg CG, Ekblom P (eds) Gene expression during normal and malignant differentiation. Academic, Orlando, pp 13–32
Ingber DE, Madri J A, Folkman J (1986) A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119: 1768–1775
Ingber DE, Madri J A, Folkman J (1987) Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol 23: 387–394
Ishikawa F, Miyazono K, Hellman U, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557–562
Jaffe EA, Nachman RL, Becker CG, Minick CR (1972) Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 52: 2745–2756
Jakob W, Jentzsch KD, Mauersberger B, Oehme P (1977) Demonstration of angiogenesis activity in the corpus luteum of cattle. Exp Pathol 13: 231–236
Kadish JL, Butterfield CE, Folkman J (1979) The effect of fibrin on cultured vascular endothelial cells. Tissue Cell 11: 99–108
Kalebic T, Garbisa S, Glaser B, Liotta LA (1983) Basement membrane collagen: degradation by migrating endothelial cells. Science 221: 281–283
Keski-Oja J, Lyons RM, Moses HL (1987) Inactive secreted form(s) of transforming growth factor-beta: activation by proteolysis. J Cell Biochem [Suppl] 11 a: 60
Kessler D, Langer R, Pless N, Folkman J (1976) Mast cells and tumor angiogenesis. Int J Cane 18: 703–709
Kissun RD, Hill CR, Garner A, Phillips P, Kumar S, Weiss JB (1982) A low-molecular-weight angiogenic factor in cat retina. Br J Ophthalmol 66: 165–169
Klagsbrun M, Shing Y (1985) Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors. Proc Natl Acad Sci USA 82: 805–809
Klagsbrun M, Knighton D, Folkman J (1976) Tumor angiogenesis in cells grown in tissue culture. Cancer Res 36: 110–114
Klagsbrun M, Sasse J, Sullivan R, Smith JA (1986) Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Proc Natl Acad Sci USA 83: 2448–2452
Knighton DR, Hunt TK, Scheuenstahl H, Halliday BJ, Werb Z, Banda MJ (1983) Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283–1285
Knighton D, Schumerth S, Fiegel V (1987) Environmental regulation of macrophage angiogenesis. In: Rifkin DB, Klagsbrun M (eds) Current communications in molecular biology. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 150–154
Koch AE, Polverini PJ, Leibovich SJ (1986) Stimulation of neovascularization by human rheumatoid synovial tissue macrophages, Arthritis Rheum 29: 471–479
Koos R, Lemaire W (1983) Evidence for an angiogenic factor from rat follicles. In: Greenwald GS, Terranova PF (eds) Factors regulating ovarian function. Raven, New York, pp 191–195
Kramer P (1971) Heparan-sulfates of cultured cells: I. Membrane-associated in cellsap species in Chinese hamster cells. Biochemistry 10: 1443–1445
Kramer RH, Vogel GL, Nicolson GL (1982) Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. J Biol Chem 257: 2678–2686
Kreisle RA, Ershler WB (1988) Investigation of tumor angiogenesis in an Id mouse model: role of host-tumor interactions. JNCI 80: 849–854
Kuli FC Jr, Brent DA, Parikh I, Cuatrecasas P (1987) Chemical identification of a tumor-derived angiogenic factor. Science 236: 843–845
Kurachi K, Davie EW, Strydom DJ, Riordan JF, Yallee BL (1985) Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry 24: 5494–5499
Langer R, Folkman J (1976) Polymers for the sustained release of proteins and other macromolecules. Nature 263: 797–800
Langer RS, Conn H, Vacanti JP, Haudenschild C, Folkman J (1980) Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci USA 77: 4431–4335
Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P (1984) Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 121: 184–188
Lawrence DA, Pircher R, Jullien P (1985) Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta- TGF under acidic conditions. Biochem Biophys Res Commun 133: 1026–1034
Leibovich SJ, Ross R (1975) The role of macrophages in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 78: 71–100
Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, NuScir N (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-a. Nature 329: 630–632
Lemmon SK, Bradshaw R (1983) Purification and partial characterization of bovine pituitary fibroblast growth factor. J Cell Biochem 21: 195–208
Linhardt RJ, Grant A, Coonery CL, Langer R (1982) Differential anticoagulant activity of heparin fragments prepared using microbial heparinase. J Biol Chem 257: 7310–7313
Lobb RR, Fett JW (1984) Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography. Biochemistry 23: 6295–6299
Lobb RR, Sasse J, Shing Y, D’Amore PA, Sullivan R, Jacobs J, Klagsbrun M (1986) Purification and characterization of heparin-binding growth factors. J Biol Chem 261: 1924–1928
Maciag T, Hoover GA, Stemerman MB, Weinstein R (1981) Serial propagation of endothelial cells in vitro. J Cell Biol 91: 420–426
Maciag T, Hoover GA, van der Spek J, Stemerman MB, Weinstein R ( 1982 a) Growth and differentiation of human umbilical-vein endothelial cells in culture. In: Book A, Sato GH, Pardee AB, Sirbasku DA Growth of cells in hormonally defined media. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 525–538
Maciag T, Kadish J, Wilkins L, Stemerman MB, Weinstein R (1982 b) Organization behavior of human umbilical vein endothelial cells. J Cell Biol 94: 511–520
Maciag T, Mehlman T, Friesel R, Schreiber AB (1984) Heparin binds endothelial cell growth factor, the principal cell mitogen in bovine brain. Science 225: 932–935
Madri J, Williams SK (1983) Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 97: 153–165
Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell GI, Ross R (1988) Induction of transforming growth factor-a in activated human alveolar macrophages. Cell 53: 285–293
Makris A, Ryan KJ, Yasumizu T, Hill CL, Zetter BR (1984) The non-luteal porcine ovary as a source of angiogenic activity. Endocrinology 15: 1672–1677
Marks RM, Roche WR, Czerniecki M, Penny R, Nelson DS (1986) Mast cell granules cause proliferation of human microvascular endothelial cells. Lab Invest 55: 289–294
Marquardt H, Hunkapiller MW, Hood LE, Todaro GJ (1984) Rat transforming growth factor type I: structure and relationship to epidermal growth factor. Science 223: 1079–1082
Matsubara T, Ziff M (1987) Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest 79: 1440–1446
Mazanet R, Franzini-Armstrong C (1982) Scanning electron microscopy of pericytes in rat red muscle. Microvasc Res 23: 361–369
Miyazono K, Okabe T, Urabe A, Takaku F, Heldin C-H (1987) Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 262: 4098–4103
Montesano R, Orci L, Vassalli P (1983) In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 97: 1648–1652
Montesano R, Vassali JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7297–7301
Mormede P, Baird A, Pigeon P (1985) Immunoreactive fibroblast growth factor (FGF) in rat tissues: molecular weight forms and the effects of hypophysectomy. Biochem Biophys Res Commun 120: 1108–1113
Moscatelli D, Silverstein J, Manejias R, Rifkin DB (1987) Mr 25000 heparin binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci USA 84: 5778–5782
Moses HL, Tucker RF, Leof EB, Coffey RJ, Halper J, Shipley GD (1985) Type beta transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells (Cold Spring Harbor) 3: 65–71
Moses MA, Sudhalter J, Langer R (1988) A Cartilage-derived Collagenase inhibitor of capillary all proliferation. Invest opth 29: 95
Muller G, Behrens J, Nussbaumer U, Bohlen P, Birchmeier W (1987) Inhibitory action of transforming growth factor-ß on endothelial cells. Proc Natl Acad Sci USA 84: 5600–5604
Muthukkarauppan VR, Auerbach R (1979) Angiogenesis in the mouse cornea. Science 205: 1416–1417
Nicosia RF, Tchao R, Leighton J (1982) Histotypic angiogenesis in vitro: light microscopic, ultrastructural and radioautographic. In Vitro 18: 538–549
Odedra R, Weiss JB (1987) A synergistic effect on micro vessel cell proliferation between basic fibroblast growth factor (FGFb) and endothelial cell stimulating angiogenesis factor ( ESAF ). Biochem Biophys Res Commun 143: 947–953
Orlidge A, D’Amore P (1986) Pericyte and smooth muscle cell modulation of endothelial cell proliferation. J Cell Biol 103:471 a
Orlidge A, D’Amore P (1988) Endothelial cell-pericyte cocultures produce activated TGF-ß which inhibits endothelial cell growth. Invest Ophthalmol Vis Sci 29: 109
Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, StrinScifer B (1982) DNA synthesis in coronary collaterals after coronary occlusion in the conscious dog. Am J Physiol 242 (Heart Circ Physiol 11): H1031–H1037
Pledger WJ, Stiles CD, Antoniades HN, Scher CD (1978) An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci USA 75: 2839–2843
Pober JS, Bevilacqua MP, Mendrick DL, LaPierre LA, Fiers W, Gimbrone MA Jr (1986 a) Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 137: 1680–1687
Pober JS, Gimbrone MA Jr, LaPierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA (1986 b) Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 137: 1893–1896
Pober JS, LaPierre LA, Stophen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick DL, Gimbrone MA Jr (1987) Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 138: 3319–3324
Polverini P, Cotran R, Gimbrone M Jr, Unanue E (1977) Activated macrophages induce vascular proliferation. Nature 269: 804–806
Polverini P, Leibovich S (1984) Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51: 635–642
Potts M, Dopplet S, Taylor S, Folkman J, Neer R, Potts JT Jr (1984) Protamine: a powerful in vivo inhibitor of bone resorption. Calcif Tissue Int 36: 189–193
Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA, Caput D (1989) High molecular weight forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA (86: 1836 - 1840 )
Presta M, Moscatelli D, Silverstein JJ, Rifkin DB (1986) Purification from a human hepatoma cell line of a basic FGF like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis and migration. Mol Cell Biol 6:4060–4066
Presta M, Rusnati M, Maier JAM, Ragnotti G (1988) Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. Biochem Biophys Res Commun 155: 1161
Proia AD, Chandler MB, Haynes WL, Smith CS, Suvarnamani C, Erkel F, Klintworth GK (1988) Quantitation of corneal neovascularization using computerized image analysis. Lab Invest 58: 473–479
Rastinejad F, Polverini PJ and Bouck NP (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. CELL 56: 345–355
Rifkin DB, Gross JL, Moscatelli D, Jaffe E (1982) Proteases and angiogenesis: production of plasminogen activator and collagenase by endothelial cells. In: Nossel H, Vogel HJ (eds) Pathobiology of the endothelial cell. Academic, New York, pp 191–197
Riordan JF, Vallee BL (1988) Human angiogenin, an organogenic protein. Br J Cancer 57: 587–590
Risau W, Lemmon V (1988) Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125: 441–450
Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1981) New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78: 5339–5343
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–171
Rogelj S, Weinberg RA, Fanning P, Klagsbrun M (1988) Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature 331: 173–175
Ryan T (1970) Factors influencing the growth of vascular endothelium in the skin. Br J Dermatol 82: 99–111
Ryan TJ, Barnhill RL (1983) Physical factors and angiogenesis. Ciba Found Symp: 80–94
Ryan TJ, Stockley AT (1980) Mechanical versus biochemical factors in angiogenesis. Microvasc Res 20: 258–259
Rybak SM, Vallee BL (1988) Base cleavage specificity of angiogenin with Saccharomyces cerevisiae and Escherichia coli 5S RNA’s. Biochemistry 27: 2288–2294
Rybak SM, Fett JW, Yao QZ, Vallee BL (1987) Angiogenin mRNA in human tumor and normal cells. Biochem Biophys Res Commun 146: 1240–1248
Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T (1986) Transforming gene from human stomach cancers and a non-cancerous portion of stomach mucosa. Proc Natl Acad Sci USA 83: 3997–4001
Saksela O, Moscatelli D, Sommer A, Rifkin DB (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107: 743–751
Schaper W (1981) The collateral circulation of the heart. American Elsevier, New York
Schaper W, DeBrabander M, Lewi P (1971) DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 28: 671–679
Schor AM, Schor SL, Kumar S (1979) Importance of a collagen substratum for stimulation of capillary endothelial cell proliferation by tumor angiogenesis factor. Int J Cancer 24: 225–234
Schreiber AB, Kenney J, Kowalski WJ, Friesel R, Mehlman T, Maciag T (1985) Interaction of endothelial cell growth factor with heparin: characterization of receptor and antibody recognition. Proc Natl Acad Sci USA 82: 6138–6142
Schreiber AB, Winkler ME, Derynck R (1986) Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 232: 1250–1253
Schweigerer L, Malerstein B, Gospodarowicz D (1987 a) Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem Biophys Res Commun 143: 997–1004
Schweigerer L, Neufeld G, Friedman J, Abrahan JA, Fiddes JC, Gospodarowicz D (1987 b) Capillary endothelial cells express basic fibroblast growth factor. Nature 325: 257–259
Selye H (1965) The mast cells. Butterworth, Washington, p 293
Senger DR, Galli SJ, Dvorak AM, Perrujzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983–985
Seyedin SM, Thomas TC, Thompson AY, Rosen DM, Piez KA (1985) Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci USA 82: 2267–2271
Seyedin SM, Thompson AY, Bentz H, Rosen DM, McPherson JM, Conti A, Siegel NR, Galluppi GR, Piez KA (1986) Cartilage-inducing factor-A. J Biol Chem 261: 5693–5695
Shapiro R, Vallee BL (1987) Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci USA 84: 2238–2241
Shapiro R, Riordan JF, Vallee BL (1986) Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 25: 3527–3532
Shapiro R, Strydom DJ, Olson KA, Vallee BL (1987 a) Isolation of angiogenin from normal human plasma. Biochemistry 26: 5141–5146
Shapiro R, Weremowicz S, Riordan JF, Vallee BL (1987 b) Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues. Proc Natl Acad Sci USA 84: 8783–8787
Sherry B, Cerami A (1988) Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 107: 1269–1277
Shing Y, Folkman J, Sullivan R, Butterfleld C, Murray J, Klagsbrun M (1984) Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223: 1296–1299
Shing Y, Folkman J, Haudenschild C, Lund D, Crum R, Klagsbrun M (1985) Angio- genesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Bio- chem 29: 275–287
Smith S, Basu P (1970) Mast cells in corneal immune reaction. Can J Ophthalmol 5: 175–183
Sommer A, Brewer MT, Thompson RC, Moscatelli D, Presta M, Rifkin DB (1987) A form of human fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun 42: 543–550
Splawinski J, Michna M, Palczak R, Konturek S, Splawinski B (1988) Angiogenesis: quantitative assessment by the chick chorioallantoic membrane assay. Meth Find Exp Clin Pharmacol 10: 221–226
Sporn MB, Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332: 217–219
Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105: 1039–1045
St. Clair DK, Rybak SM, Riordan JF, Vallee BL (1987) Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes. Proc Natl Acad Sci USA 84: 8330–8334
Stangroom JE, Weavers R (1962) Anticoagulant activity of equine follicular fluid. J ReprodFertil 3: 269–282
Starkey JR, Crowle PK, Taubenberger S (1988) Mast-cell deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42: 48–52
Strydom DJ, Fett JW, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL (1985) Amino acid sequence of human tumor-derived angiogenin. Biochemistry 24: 5486–5494
Sullivan R, Klagsbrun M (1985) Purification of cartilage-derived growth factor by heparin affinity chromatography. J Biol Chem 260: 2399–2401
Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T (1987) cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activities. Proc Natl Acad Sci USA 84: 2980–2984
Takehara K, LeRoy EC, Grotendorst GR (1987) TGF-p inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49: 415–422
Taylor CM, Weiss JB (1984) The chick vitelline membrane as a new test system for angiogenesis and antiangiogenesis. Int J Microcirc Clin Exp 3: 337
Taylor S, Folkman J (1982) Protamine is an inhibitor of angiogenesis. Nature 297: 307–31
Terranova VP, DiFlorio R, Lyall RM, Hie S, Friesel R, Maciag T (1985) Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol 101: 2330–2334
Thakral K, Goodson W, Hunt T (1979) Stimulation of wound blood vessel growth by wound macrophages. J Surg Res 26: 430
Thomas KA (1987) Fibroblast growth factors. FASEB J1: 434–40
Thomas K, Gimemez-Gallego G (1986) Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci 11: 81–84
Thomas KA, Rios-Candelore M, Fitzpatrick S (1984) Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc Natl Acad Sci USA 81: 357–361
Thomas KA, Riley MC, Lemmon SK, Baglan NC, Bradshaw RA (1980) Brain fibro-blast growth factor. J Biol Chem 255: 5517–5520
Thompson JA, Anderson KD, DiPietro JM, Zweibel JA, Zametta M, Anderson WF, Maciag T (1988) Site-directed neovessel formation in vivo. Science 241: 1349–1352
Thompson WD, Campbell R, Evans T (1985) Fibrin degradation response in the chick embryo chorioallantoic membrane. J Pathol 145: 27–37
Thornton S, Mueller S, Levine E (1983) Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 222: 623–625
Tilton RG, Kilo C, Williamson JR (1979) Pericyte-endothelial relationships in cardiac and skeletal muscle capillaries. Microvasc Res 18: 325–335
Tilton RG, Miller EJ, Kilo C, Williamson JR (1985) Pericyte form and distribution in rat retinal and uveal capillaries. Invest Ophthalmol Vis Sci 26: 68–73
Todaro GJ, Fryling C, DeLarco JE (1980) Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77: 5258–5262
Tuan D, Smith S, Folkman J, Merler E (1973) Isolation of the non-histone proteins of rat Walker carcinoma and their association with tumor angiogenesis. Biochemistry 12: 3159–3165
Tucker RF, Shipley GD, Moses HL, Holley RW (1984) Growth inhibitor from BSC–1 cells closely related to platelet type beta transforming growth factor. Science 226: 705–707
Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V (1983) Lymphoma cell mediated degradation of sulfated proteoglycans in the subendothelial cell ex-tracellular matrix: relationship to tumor metastasis. Cancer Res 43: 2704–2711
Vlodavsky I, Sullivan R, Fridman R, Sasse J, Folkman J, Klagsbrun M (1986) Heparin-binding endothelial cell growth factor produced by endothelial cells and sequestered by the endothelial extracellular matrix. J Cell Biol 103 (2):98 a
Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M (1987 a) Endothelial cell-derived basic fibroblast growth factor; synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84: 2292–2296
Vlodavsky I, Friedman R, Sullivan R, Sasse J, Klagsbrun M (1987 b) Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell-associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol 131: 402–408
Wahl SM, Hunt DA Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, Sporn MB (1987) Transforming growth-factor beta ( TGF-beta) induces monocyte Chemotaxis and growth factor production. Proc Natl Acad Sci USA 84: 5788–5792
Weiner HL, Weiner LH, Swain JL (1987) Tissue distribution and developmental expression of the messenger RNA encoding angiogenin. Science 237: 280–282
Whalen GF, Zetter BR (1989) Angiogenesis and wound healing. In: Diegelman RF, Cohen K, Lindblatt WJ (eds) Wound healing: Biochemical and clinical aspects. Saunders, Philadelphia (in press)
Zeleznik A, Schuller H, Reichert L Jr (1981) Gonadatotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 109: 356–362
Zetter BR (1980) Migration of capillary endothelial cells is stimulated by tumor-derived factors. Nature 285: 41–43
Zhan X, Bates B, Hu X, Goldfarb M (1988) The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors. Mol Cell Biol 8: 3487
Ziehe M, Jones J, Gullino P (1982) Role of prostaglandin El and copper in angiogenesis. JNCI 69: 475–482.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Klagsbrun, M., Folkman, J. (1990). Angiogenesis. In: Sporn, M.B., Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors II. Handbook of Experimental Pharmacology, vol 95 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74781-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-74781-6_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74783-0
Online ISBN: 978-3-642-74781-6
eBook Packages: Springer Book Archive